# Progress Note 01 — Initial plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Elisabeth of Austria (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI030-SYN
- Date: 2026-02-03
- Fictional facility: St. Posthumous Health Center
- Fictional author: Adelheid Marchetti-Osei, MD
- Calendar frame: modern shifted

## Subjective

The patient participates in this fictional visit for new patient visit for weight loss, fatigue, ankle swelling and dizziness: history, examination with orthostatic vital signs, ECG, blood tests, depression and safety screening, a start to nutrition with thiamine, and an eating disorders psychiatry referral. **S**

## Objective

Hemoglobin: 11.2 g/dL (low); MCV: 93 fL; White cell count: 3.4 10*3/uL (low); Platelets: 168 10*3/uL; Sodium: 136 mmol/L; Potassium: 3.6 mmol/L; Urea nitrogen: 21 mg/dL (high); Creatinine: 0.56 mg/dL (low); Glucose: 68 mg/dL (low); Magnesium: 1.8 mg/dL; Phosphate: 3 mg/dL; Albumin: 4.1 g/dL; ALT: 52 U/L (high); TSH: 2.2 mIU/L; CRP: 1 mg/L; Tissue transglutaminase IgA: 0.8 U/mL; Ferritin: 64 ng/mL; 25-hydroxyvitamin D: 22 ng/mL (low); QTc: 438 ms; eGFR: 107 mL/min/1.73 m²; PHQ-9: 16. All results are synthetic.

BP 96/62 mmHg; pulse 52 bpm; respirations 14/min; temperature 36 °C; oxygen saturation 98% on room air; weight 47.4 kg; BMI 16 kg/m². All vital signs are synthetic.

## Assessment

Active problems: Weight loss to a body mass index of 16.0 (47.4 kg at 172 cm), about 6 kg over six months, with fatigue, swelling of both ankles, dizziness on standing, slow pulse and cold intolerance; cause not established at intake; a restrictive eating disorder suspected, with thyroid disease, celiac disease, diabetes, malignancy and adrenal insufficiency to be excluded; eating disorders psychiatry consultation requested; Major depressive disorder, recurrent, moderate, with persistent grief for her son, who died five years ago; passive thoughts of death without intent or plan at intake. Strengths and supports remain part of the care plan. **S**

## Medication changes

- Started: Thiamine 100 mg tablet, one by mouth daily for 14 days, starting before the meal plan **S**
- Started: Cholecalciferol 50 microgram (2,000 IU) capsule, one by mouth daily **S**

## Plan

- Eating disorders psychiatry consultation in one week to confirm the diagnosis, decide the level of care, and lead a multidisciplinary plan. Guideline: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders, Fourth Edition (2023); Eating Disorders: A Guide to Medical Care (AED Medical Care Standards Guide), 4th edition (2021) **S**
- Medical assessment and stabilization: orthostatic vital signs and temperature, ECG, blood count, electrolytes with phosphate and magnesium, glucose, kidney and liver tests, albumin, TSH, CRP, ferritin and vitamin D; admission criteria explained; electrolytes, phosphate and magnesium to be rechecked three to four days after the meal plan starts, then weekly for the first weeks. Guideline: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders, Fourth Edition (2023); Medical Management of Restrictive Eating Disorders in Adolescents and Young Adults (position paper) (2022); Eating Disorders: A Guide to Medical Care (AED Medical Care Standards Guide), 4th edition (2021) **S**
- Refeeding risk: thiamine 100 mg daily before and during the first two weeks, and a starting meal plan of about 1,600 kcal a day in three meals and two snacks, increased by about 200 to 300 kcal every few days. Guideline: Medical Management of Restrictive Eating Disorders in Adolescents and Young Adults (position paper) (2022); ASPEN Consensus Recommendations for Refeeding Syndrome (2020) **S**
- Collaborative safety plan with warning signs, coping steps, people to contact including her travelling companion, the clinic number, the 988 Suicide & Crisis Lifeline and local emergency numbers abroad; medicines dispensed in small supplies and kept by her companion. Guideline: VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024) **S**
- Privacy: the chart is flagged as restricted, access is audited, she is booked under a scheduling alias at the first or last appointment of the day, and weights are discussed only in the consulting room. Guideline: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders, Fourth Edition (2023) **S**
